|
|
||||||||
1 Departments of Endocrinology and Metabolism,
2 Oncology, Section of Pathology and
3 Surgery, University of Pise, Pise, Italy
4 Center for Molecular Medicine and Division of Endocrinology & Metabolism, University of Connecticut School of Medicine, Farmington, Connecticut, USA
(Requests for offprints should be addressed to F Cetani; Email: cetani{at}endoc.med.unipi.it)
Early onset of primary hyperparathyroidism (PHPT) and multiglandular involvement suggest a familial form in which germline mutation of a PHPT-related gene(s) and a somatic event at the same locus can be often demonstrated. We investigated the involvement of multiple endocrine neoplasia type 1 (MEN1) and HRPT2 genes in a 39-year-old man with recurrent PHPT. PHPT was firstly diagnosed at the age of 21 and the patient had two recurrences separated by extended periods of normocalcemia. This unusual history prompted us to investigate other family members and study the MEN1 and HRPT2 genes. An HRPT2 germline missense mutation in exon 3 (R91P) was found in the index case, which was associated with different HRPT2 somatic alterations in each of the three examined parathyroid tumors. These findings are consistent with Knudsons two hit concept of biallelic inactivation of classical tumor suppressor genes. Screening of 15 asymptomatic relatives was negative for the R91P germline mutation. All the three abnormal parathyroid specimens showed cystic features at histology and were negative for parafibromin immunostaining. In one specimen, diffuse parafibromin staining was evident in a rim of normal parathyroid tissue surrounding the adenomatous lesion. Our study shows that different somatic genetic events at the HRPT2 locus are responsible for the asynchronous occurrence of multiple adenomas in a patient carrying an HRPT2 germline mutation. The finding of diffuse parafibromin staining in a rim of normal parathyroid tissue, but not in the contiguous adenomatous lesion, reinforces the concept that loss of parafibromin expression is responsible for the development of parathyroid tumors in this setting.
This article has been cited by other articles:
![]() |
M. A Hahn, V. M Howell, A. J Gill, A. Clarkson, G. Weaire-Buchanan, B. G Robinson, L. Delbridge, O. Gimm, W. D Schmitt, B. T Teh, et al. CDC73/HRPT2 CpG island hypermethylation and mutation of 5'-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors Endocr. Relat. Cancer, February 18, 2010; 17(1): 273 - 282. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A Hahn, J. McDonnell, and D. J Marsh The effect of disease-associated HRPT2 mutations on splicing J. Endocrinol., June 1, 2009; 201(3): 387 - 396. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Masi, L. Barzon, M. Iacobone, G. Viel, A. Porzionato, V. Macchi, R. De Caro, G. Favia, and G. Palu Clinical, genetic, and histopathologic investigation of CDC73-related familial hyperparathyroidism Endocr. Relat. Cancer, December 1, 2008; 15(4): 1115 - 1126. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |